Sherpa Healthcare Partners — Full Portfolio
9 tracked investments · listed companies and verified rows first
An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsLAVLilly Asia VenturesQuan Capital3E Bioventures Capital3H Health InvestmentYuanBio Venture Capital
Bota offers engineered protein solutions through strain optimization and screening, leveraging proprietary datasets to increase protein yield while reducing production costs for industrial biotech applications.
Advanced ManufacturingBiotechDeep TechFoodTechNew Materials
Dr. Cheryl Cui(CEO)
Co-investorsHongShan Capital GroupNSG VenturesSource Code CapitalMatrix Partners China
Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform.
BiotechDeep TechHealthtechBoston, US
Novalia Pishesha(Founder)inHidde Ploegh(Founder)Novalia Pishesha, PhD(Co-founder, BoD, SAB)Hidde L. Ploegh, PhD(Co-Founder, SAB)Harvey F. Lodish, PhD(Co-Founder, BoD)Xiaohong Sang(Executive Officer)
Co-investorsBill & Melinda Gates Foundation
ClinChoice operates a network of investigator sites that participate in clinical studies to support drug and device development.
BiotechHealthtechMedical DevicesPhiladelphia, US
Dr. John Balian(CEO)
Co-investorsDFJ DragonFundDraper AssociatesDraper DragonApricot CapitalLegend CapitalLilly Asia Ventures
EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform.
BiotechDeep TechHealthtech
Co-investorsLAVLilly Asia VenturesWI Harper Group3H Health InvestmentAlwin CapitalBioTrack Capital+2 more
Epimab Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of bispecific antibodies using proprietary technology platforms including FIT-Ig® and MAT-Fab.
BiotechHealthtechMedical DevicesShanghai, CN
Wu Chenbing(Founder/Expert)
Co-investorsDecheng CapitalShangBay Capital LLCTCG Labs3E Bioventures Capital
Neukio is a biopharmaceutical company developing iPSC-derived cell technology platforms and next-generation off-the-shelf, mass-producible immune cell products (such as NK cells) to treat solid tumors and autoimmune diseases.
BiotechDeep TechHealthtech
Liqun Wang(Founder)
Co-investorsPan-Lin CapitalAlwin CapitalIDG CapitalLilly Asia Ventures
Singleron Biotechnologies develops single-cell and single-nucleus sequencing kits and solutions for transcriptome analysis of biological samples.
BiotechMedical DevicesCologne, DE
Co-investorsARCH Venture PartnersLAVLilly Asia VenturesLake Bleu CapitalMSA CapitalSBCVC
Therorna develops circular RNA-based therapeutic candidates and preventive medicines for diseases with unmet clinical needs.
AI & Machine LearningBiotechDeep TechHealthtechBeijing, CN
Co-investorsCenova CapitalQuan Capital3H Health InvestmentMSA Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.